A cross-sectional study by Hana et al found a positive association between the 2 markers and total bilirubin levels in HCC patients.[26] Furthermore, our research revealed a significant association between abnormal PIVKA-II and AFP levels and TB and GGT in HCC patients. This evidence concerns the gene AFP and hepatocellular carcinoma.